Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study-Reference-Cited by-同舟云学术

Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study

Published:2021-07 Issue: Volume:151 Page:150-158
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Hompland Ivar^ORCID,Ferrari Stefano^ORCID,Bielack Stefan,Palmerini Emanuela,Hall Kirsten S.,Picci Pierro^ORCID,Hecker-Nolting Stefanie,Donati Davide M.^ORCID,Blattmann Claudia,Bjerkehagen Bodil,Staals Eric^ORCID,Kager Leo^ORCID,Gambarotti Marco^ORCID,Kühne Thomas,Eriksson Mikael,Ferraresi Virginia,Kevric Matthias,Biagini Roberto^ORCID,Baumhoer Daniel^ORCID,Brosjø Otte,Comandone Alessandro,Schwarz Rudolf,Bertulli Rossella^ORCID,Kessler Torsten,Hansson Lina,Apice Gaetano,Heydrich Björn-N.,Setola Elisabetta,Flörcken Anne,Ruggieri Pietro^ORCID,Krasniqi Fatime,Hofmann-Wackersreuther Gerda,Casali Paolo,Reichardt Peter,Smeland Sigbjørn

Funder

Swedish Cancer Society

Stiftung Deutsche Krebshilfe

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Advanced chondrosarcomas: role of chemotherapy and survival;Italiano;Ann Oncol,2013

2. Soft tissue and bone tumours,2020

3. Chondrosarcoma in Norway 1990–2013; an epidemiological and prognostic observational study of a complete national cohort;Thorkildsen;Acta Oncol,2019

4. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group;Grimer;Eur J Canc,2007

5. Dedifferentiated chondrosarcoma: a survival analysis of 159 cases from the SEER database (2001-2011);Strotman;J Surg Oncol,2017

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma;Current Oncology;2024-01-19

2. IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience;BMC Cancer;2023-09-26

3. Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO‐B.O.S.S.);Cancer;2023-08-02

4. Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials;Cancers;2023-08-01

5. Construction of novel predictive tools for post-surgical cancer-specific survival probability in patients with primary chondrosarcoma and external validation in Chinese cohorts: a large population-based retrospective study;Journal of Cancer Research and Clinical Oncology;2023-07-19